top of page
Abstract Line Pattern

Colorectal Cancer (CRC)

Colorectal Cancer (CRC)

(HARMONi-GI3) A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination With FOLFOX Versus Bevacizumab in Combination With FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer

Principal Investigator (PI)

Clinical Trials.gov ID

Key Eligibility

Protocol #

SPONSOR

Summit Therapeutics
bottom of page